Secondary Analysis of a Randomized Phase 1/2 Trial of Pembrolizumab with or without Radiation Therapy for Metastatic Non-small Cell Lung Cancer-MedSci.cn

Secondary Analysis of a Randomized Phase 1/2 Trial of Pembrolizumab with or without Radiation Therapy for Metastatic Non-small Cell Lung Cancer

Chen, D; Chang, JY; Heymach, J; Tang, C; Nguyen, QN; Welsh, JW

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020; 108 (3): S73

科室
- - 订阅+
  - 更多科室
工具
服务